Your browser doesn't support javascript.
loading
The Parkinson's disease risk gene cathepsin B promotes fibrillar alpha-synuclein clearance, lysosomal function and glucocerebrosidase activity in dopaminergic neurons.
Jones-Tabah, Jace; He, Kathy; Senkevich, Konstantin; Karpilovsky, Nathan; Deyab, Ghislaine; Cousineau, Yuting; Nikanorova, Daria; Goldsmith, Taylor; Del Cid Pellitero, Esther; Chen, Carol X-Q; Luo, Wen; You, Zhipeng; Abdian, Narges; Pietrantonio, Isabella; Goiran, Thomas; Ahmad, Jamil; Ruskey, Jennifer A; Asayesh, Farnaz; Spiegelman, Dan; Waters, Cheryl; Monchi, Oury; Dauvilliers, Yves; Dupré, Nicolas; Miliukhina, Irina; Timofeeva, Alla; Emelyanov, Anton; Pchelina, Sofya; Greenbaum, Lior; Hassin-Baer, Sharon; Alcalay, Roy N; Milnerwood, Austen; Durcan, Thomas M; Gan-Or, Ziv; Fon, Edward A.
  • Jones-Tabah J; McGill Parkinson Program, Neurodegenerative Diseases Group, Department of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital, McGill University, Montreal, Québec, Canada.
  • He K; Department of Neurology and Neurosurgery, McGill University, Montréal, Canada.
  • Senkevich K; McGill Parkinson Program, Neurodegenerative Diseases Group, Department of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital, McGill University, Montreal, Québec, Canada.
  • Karpilovsky N; McGill Parkinson Program, Neurodegenerative Diseases Group, Department of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital, McGill University, Montreal, Québec, Canada.
  • Deyab G; Department of Neurology and Neurosurgery, McGill University, Montréal, Canada.
  • Cousineau Y; McGill Parkinson Program, Neurodegenerative Diseases Group, Department of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital, McGill University, Montreal, Québec, Canada.
  • Nikanorova D; McGill Parkinson Program, Neurodegenerative Diseases Group, Department of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital, McGill University, Montreal, Québec, Canada.
  • Goldsmith T; Department of Neurology and Neurosurgery, McGill University, Montréal, Canada.
  • Del Cid Pellitero E; Research Department, Bioinformatics Institute, Saint-Petersburg, Russia.
  • Chen CX; Early Drug Discovery Unit (EDDU), Montreal Neurological Institute-Hospital, McGill University, Montreal, Canada.
  • Luo W; McGill Parkinson Program, Neurodegenerative Diseases Group, Department of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital, McGill University, Montreal, Québec, Canada.
  • You Z; Early Drug Discovery Unit (EDDU), Montreal Neurological Institute-Hospital, McGill University, Montreal, Canada.
  • Abdian N; Early Drug Discovery Unit (EDDU), Montreal Neurological Institute-Hospital, McGill University, Montreal, Canada.
  • Pietrantonio I; Early Drug Discovery Unit (EDDU), Montreal Neurological Institute-Hospital, McGill University, Montreal, Canada.
  • Goiran T; Early Drug Discovery Unit (EDDU), Montreal Neurological Institute-Hospital, McGill University, Montreal, Canada.
  • Ahmad J; McGill Parkinson Program, Neurodegenerative Diseases Group, Department of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital, McGill University, Montreal, Québec, Canada.
  • Ruskey JA; McGill Parkinson Program, Neurodegenerative Diseases Group, Department of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital, McGill University, Montreal, Québec, Canada.
  • Asayesh F; McGill Parkinson Program, Neurodegenerative Diseases Group, Department of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital, McGill University, Montreal, Québec, Canada.
  • Spiegelman D; Department of Neurology and Neurosurgery, McGill University, Montréal, Canada.
  • Waters C; McGill Parkinson Program, Neurodegenerative Diseases Group, Department of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital, McGill University, Montreal, Québec, Canada.
  • Monchi O; Department of Neurology and Neurosurgery, McGill University, Montréal, Canada.
  • Dauvilliers Y; McGill Parkinson Program, Neurodegenerative Diseases Group, Department of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital, McGill University, Montreal, Québec, Canada.
  • Dupré N; Department of Human Genetics, McGill University, Montréal, Canada.
  • Miliukhina I; McGill Parkinson Program, Neurodegenerative Diseases Group, Department of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital, McGill University, Montreal, Québec, Canada.
  • Timofeeva A; Department of Neurology, College of Physicians and Surgeons, Columbia University Medical Center, NY, USA.
  • Emelyanov A; Department of Neurology and Neurosurgery, McGill University, Montréal, Canada.
  • Pchelina S; Département de radiologie, radio-oncologie et médecine nucléaire, Université de Montréal, Montréal, QC, Canada.
  • Greenbaum L; Centre de recherche de l'Institut universitaire de gériatrie de Montréal, Montréal, QC, Canada.
  • Hassin-Baer S; National Reference Center for Narcolepsy, Sleep Unit, Department of Neurology, Gui-de-Chauliac Hospital, CHU Montpellier, University of Montpellier, Montpellier, France.
  • Alcalay RN; Neuroscience Axis, CHU de Québec - Université Laval, Quebec City, G1V 4G2, Canada.
  • Milnerwood A; Department of Medicine, Faculty of Medicine, Université Laval, Québec, QC, G1V 0A6, Canada.
  • Durcan TM; Institute of the Human Brain of RAS, St. Petersburg, Russia.
  • Gan-Or Z; First Pavlov State Medical University of St. Petersburg, Saint-Petersburg, Russia.
  • Fon EA; First Pavlov State Medical University of St. Petersburg, Saint-Petersburg, Russia.
bioRxiv ; 2023 Nov 15.
Article en En | MEDLINE | ID: mdl-38014143